Fate Therapeutics, Inc. (FATE) total debt

Total debt · fiscal 2025
$77.85M

Fate Therapeutics, Inc. (FATE) carried total debt of $77.85M at the end of fiscal 2025 (December 31, 2025). That is 8.7% lower than the $85.27M of fiscal 2024. Figures as of 18 Nov 2026, 01:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$77.85M
Change on fiscal 2024
−8.7%
Growth, 10 years
+13.7% a year
Highest on record
$109.34Mfiscal 2022
Lowest on record
$3.48Mfiscal 2013
Fiscal years on record
112012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Fate Therapeutics, Inc. total debt, in more detail

Over the ten fiscal years to 2025 total debt grew at a compound 13.7% a year. Across the 11 fiscal years on record (2012–2025), the highest was $109.34M in fiscal 2022 and the lowest $3.48M in fiscal 2013.

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

History · 11 fiscal years

Total debt by fiscal year

Fate Therapeutics, Inc. total debt, year by year

Fate Therapeutics, Inc. (FATE) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$77.85M 8.7% down0.4×
2024$85.27M 17.6% down0.3×
2023$103.54M 5.3% down0.3×
2022$109.34M—0.2×
2018$18.48M 4.3% down0.1×
2017$19.32M 50.8% up0.3×
2016$12.81M 40.6% down0.2×
2015$21.57M 9.9% up0.6×
2014$19.63M 463.7% up0.7×
2013$3.48M 6.7% down0.1×
2012$3.73M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on FATE

Fate Therapeutics, Inc., figure by figure

Fate Therapeutics, Inc. (FATE) overview: price, valuation and scorecard

Fate Therapeutics, Inc. total debt: questions and answers

How much debt does Fate Therapeutics, Inc. have?

Fate Therapeutics, Inc. (FATE) carried total debt of $77.85M at the end of fiscal 2025 (December 31, 2025). That is 8.7% lower than the $85.27M of fiscal 2024.

What is the growth rate of Fate Therapeutics, Inc.'s total debt?

Over the ten fiscal years to 2025 total debt grew at a compound 13.7% a year.

What are the highest and lowest total debt figures on record for Fate Therapeutics, Inc.?

Across the 11 fiscal years on record (2012–2025), the highest was $109.34M in fiscal 2022 and the lowest $3.48M in fiscal 2013.

How does Fate Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

How is Fate Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Fate Therapeutics, Inc. (FATE) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/FATE/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.